# CRP Apheresis in Infarct-Related Cardiogenic Shock

> **NCT07687017** · NA · NOT_YET_RECRUITING · sponsor: **Leipzig Heart Science gGmbH** · enrollment: 50 (estimated)

## Conditions studied

- Cardiogenic Shock
- Acute Myocardial Infarction (AMI)

## Interventions

- **DEVICE:** Selective C-reactive protein apheresis (PentraSorb®-CRP)
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT07687017
- **Lead sponsor:** Leipzig Heart Science gGmbH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-20
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-10-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687017, "CRP Apheresis in Infarct-Related Cardiogenic Shock". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*